Mortality Lower With Lung Volume Reduction Surgery in Emphysema

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 28, 2025.

By Elana Gotkine HealthDay Reporter

TUESDAY, Jan. 28, 2025 -- For patients with advanced emphysema, endobronchial valve placement (EBV) is associated with higher mortality and morbidity compared with lung volume reduction surgery (LVRS), according to a study presented at the annual meeting of The Society of Thoracic Surgeons, held from Jan. 24 to 26 in Los Angeles.

J.W. Awori Hayanga, M.D., M.P.H., from West Virginia University in Morgantown, and colleagues examined data from the U.S. Centers for Medicare and Medicaid Services inpatient claims database for all beneficiaries with severe emphysema undergoing either LVRS or EBV between Jan. 1, 2019, and Dec. 31, 2022, to compare outcomes.

Overall, 3,219 patients underwent lung volume reduction therapy: LVRS in 2,378 and EBV in 841. The researchers found that compared with those who underwent LVRS, EBV patients had lower Elixhauser comorbidity scores, shorter length of stay, and lower hospital charges prior to risk adjustment. Most of the LVRS procedures were minimally invasive (1,897 video-assisted thoracoscopic/robotic surgeries versus 481 open surgeries). EBV was associated with higher 30-day mortality, 30-day readmission rate, reintervention rate, and 30-day readmission with pneumothorax, higher supplementary oxygen requirement, and higher all-cause mortality at one year compared with LVRS after doubly robust risk adjustment including frailty (adjusted odds ratios, 2.68, 1.4, 17.2, 2.09, 3.49, and 1.75, respectively).

"Patients undergoing EBV placement have higher occurrences of various complications over time, often need a greater number of interventions, and even suffer higher mortality compared to those undergoing LVRS in contemporary surgical practice, where techniques have become much less invasive than they were 20 years ago when surgical options were first evaluated," Hayanga said in a statement.

Press Release

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-01-29 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords